Home Supplements How We Rate Blog
Tinospora cordifolia (Giloy)

Guduchi

Research reviewed: Up until 03/2026

Guduchi (Tinospora cordifolia (Giloy)) is a dietary supplement with 10 published peer-reviewed studies involving 301 participants, researched for Immune Function & Clinical Applications, Diabetes & Liver Health.

10
Studies
301
Participants
2000–2024
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Moderate Evidence

Immune Function & Clinical Applications

Strong
5 studies 4 of 5 positive 251 participants 4 human

Diabetes & Liver Health

Moderate
5 studies 1 of 5 positive 50 participants 1 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

0/10
Randomised
0/10
Double-Blind
0/10
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2017)
0
Study 2 (2000)
68
Study 3 (2008)
48
Study 8 (2005)
75
Study 9 (2021)
60
Study 4 (2015)
0
Study 5 (2024)
0
Study 6 (2010)
0

Research Timeline

When the studies were published

1
2000
1
2005
1
2008
1
2010
1
2015
1
2016
1
2017
1
2021
1
2023
1
2024

All Studies

Detailed breakdown of each trial. Click to expand.

Immune Function & Clinical Applications

1

Medicinal applications and immunomodulatory effects of Tinospora cordifolia

2017 ? participants Various Various
Review/Other Mixed

Study Type

Comprehensive pharmacological review

Purpose

Medicinal applications and immunomodulatory effects of Tinospora cordifolia

Dose

Various

Participants

Review

Duration

Various

Results

Anti-oxidant, anti-hyperglycaemic, hepatoprotective, cardiovascular protective, neuroprotective, anti-anxiety, adaptogenic, antimicrobial activities. Immunomodulation via macrophage activation and cytokine regulation.

How They Measured It

Systematic literature review of pharmacological and clinical studies

Read full study
2

Immunomodulatory effects of T. cordifolia in HIV-positive patients

2000 68 participants 6 months 300mg extract 3x/day
Human Study Positive

Study Type

Clinical study

Purpose

Immunomodulatory effects of T. cordifolia in HIV-positive patients

Dose

300mg extract 3x/day

Participants

68 HIV-positive patients

Duration

6 months

Results

Significant improvements in CD4+ counts and quality of life. Immunomodulatory classification objectively supported by immune marker improvements.

How They Measured It

CD4+ T cell counts, immune markers, quality of life

Read full study
3

Guduchi immunity in cancer patients receiving chemotherapy

2008 48 participants 3 months 1g/day T. cordifolia tablet
Human Study Mixed

Study Type

Clinical study

Purpose

Guduchi immunity in cancer patients receiving chemotherapy

Dose

1g/day T. cordifolia tablet

Participants

48 cancer chemotherapy patients

Duration

3 months

Results

Reduced chemotherapy-related adverse effects and maintained white blood cell counts. Immunoprotective effects in myelosuppressed patients confirmed.

How They Measured It

Blood cell counts, quality of life, adverse events

Read full study
8

Guduchi for allergic rhinitis symptoms

2005 75 participants 8 weeks 500mg extract twice daily
Human Study Positive

Study Type

RCT

Purpose

Guduchi for allergic rhinitis symptoms

Dose

500mg extract twice daily

Participants

75 allergic rhinitis patients

Duration

8 weeks

Results

Significantly reduced nasal symptoms, total IgE, and eosinophil counts vs placebo. Th1/Th2 balance modulation mechanism proposed.

How They Measured It

Nasal symptom scores, total IgE, eosinophil count

Read full study
9

Giloy in mild-moderate COVID-19 management

2021 60 participants 2 weeks 500mg twice daily
Human Study Positive

Study Type

COVID-19 clinical study

Purpose

Giloy in mild-moderate COVID-19 management

Dose

500mg twice daily

Participants

60 COVID-19 patients

Duration

2 weeks

Results

Significantly reduced inflammatory markers and recovery time. Improvements in fever, cough, and fatigue versus standard care alone.

How They Measured It

Recovery time, symptom resolution, CRP, IL-6

Read full study

Diabetes & Liver Health

4

Validate antidiabetic claims of T. cordifolia

2015 ? participants Various Various
Review/Other Mixed

Study Type

Pharmacological review

Purpose

Validate antidiabetic claims of T. cordifolia

Dose

Various

Participants

Review

Duration

Various

Results

Multiple studies confirm antidiabetic activity through alpha-glucosidase inhibition, insulin secretion enhancement, and oxidative stress reduction. Clinical trials show meaningful glucose and HbA1c reductions.

How They Measured It

Critical review of clinical and experimental studies

Read full study
5

Multifarious pharmacological paradigms of T. cordifolia

2024 ? participants Various Various
Review/Other Mixed

Study Type

Comprehensive pharmacological review

Purpose

Multifarious pharmacological paradigms of T. cordifolia

Dose

Various

Participants

Review

Duration

Various

Results

Anti-diabetic, antipyretic, anti-arthritic, antioxidant, anti-allergic, hepatoprotective, immunomodulatory. Berberine, tinosporin, and jatrorrhizine identified as key bioactives.

How They Measured It

Review of published literature

Read full study
6

Validate traditional Guduchi pharmacology through experimental and clinical data

2010 ? participants Various Various
Review/Other Mixed

Study Type

Validation review

Purpose

Validate traditional Guduchi pharmacology through experimental and clinical data

Dose

Various

Participants

Multiple studies reviewed

Duration

Various

Results

Multi-system pharmacological activity confirmed, supporting Rasayana (rejuvenative) classification. Experimental and clinical validation of antidiabetic, immunomodulatory, and hepatoprotective properties.

How They Measured It

Literature compilation of experimental and clinical data

Read full study
7

Antibacterial efficacy of T. cordifolia against AMR clinical isolates

2023 ? participants N/A Various extract concentrations
Review/Other Positive

Study Type

Antibacterial clinical study

Purpose

Antibacterial efficacy of T. cordifolia against AMR clinical isolates

Dose

Various extract concentrations

Participants

Clinical microbiology study

Duration

N/A

Results

Significant antibacterial activity against MRSA, E. coli, and Pseudomonas aeruginosa. Supports role in combating antimicrobial resistance as adjunct treatment.

How They Measured It

MIC determination, disk diffusion against clinical isolates

Read full study
10

Hepatoprotective effects of Guduchi in liver disease patients

2016 50 participants 12 weeks 400mg extract twice daily
Human Study Positive

Study Type

Hepatoprotective clinical study

Purpose

Hepatoprotective effects of Guduchi in liver disease patients

Dose

400mg extract twice daily

Participants

50 elevated liver enzyme patients

Duration

12 weeks

Results

Significant reductions in ALT, AST, ALP, and total bilirubin. Improvements in albumin levels. Safe and effective hepatoprotective activity confirmed.

How They Measured It

Liver function tests (ALT, AST, ALP), bilirubin, albumin

Read full study

Frequently Asked Questions

Common questions about Guduchi research

What does the research say about Guduchi?

There are currently 10 peer-reviewed studies on Guduchi (Tinospora cordifolia (Giloy)), involving 301 total participants. Research covers Immune modulation, Blood sugar & diabetes, Liver protection and 1 more areas. The overall evidence strength is rated as Moderate.

How strong is the evidence for Guduchi?

The evidence is currently rated as "Moderate Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (5 human studies), and reported outcomes.

What health goals has Guduchi been studied for?

Guduchi has been researched for: Immune modulation, Blood sugar & diabetes, Liver protection, Anti-inflammatory & antioxidant. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Guduchi based on human trials?

Yes, 5 out of 10 studies are human trials. Human trials carry more weight in our evidence scoring system.